Controlled release delivery system for nasal applications

US8877230B2 · kind B2 · utility

Assignee

• MATTERN PHARMA AG · LI

Inventor

• Claudia Mattern · Starnberg, DE

Key dates

• Filing date: Dec 10, 2011
• Grant date: Nov 4, 2014
• Expiry date: Dec 10, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P15/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to a pernasally administrable preparation for the controlled release of sexual hormones to the systemic circulation, in particular to a formulation which enables its active ingredient to be absorbed in a sustained manner providing a better bioavailability at very low doses and longer duration of action.